Test Overview
Test Methodology

Real-Time Reverse Transcription Polymerase Chain Reaction (PCR)/DNA Probe Hybridization

Test Usage

Provides qualitative detection of Zika virus RNA from urine collected during the acute phase of infection.
This test is intended for the evaluation of pregnant women and symptomatic nonpregnant individuals with potential exposure to Zika virus.

Reference Range *

Negative

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Tuesday, Thursday
Analytic Time

6 - 10 days

Soft Order Code
VZIKU
Synonyms
    Laboratory
    Sendout
    Reference Laboratory
    Mayo VZIKU
    Section
    Special Testing
    Specimen Requirements
    Collection Instructions

    Collect random urine in a sterile container and refrigerate.

    Normal Volume
    1 mL urine
    Minimum Volume
    0.3 mL urine
    Additional Information

    Due to similar clinical presentations, testing for RNA or IgM-class antibodies to dengue and chikungunya viruses, concurrently with Zika virus testing, is strongly recommended. For the most up-to-date Zika epidemiology and testing recommendations, visit www.cdc.gov/zika/. Test sent to Mayo Medical Laboratories.

    Billing
    CPT Code
    87662
    Fee Code
    AA379
    NY State Approved
    No